Deals -

ERM advises Maverick Ventures (Israel) II LP on a $13,000,000 million Series B investment round in Orasis Pharmaceuticals.

ERM has acted for the second fund of Maverick Ventures (Israel) II LP in a Series B investment round in Orasis Pharmaceuticals. Maverick Ventures co invested along with Sequoia Capital, Visionary Venture Fund, SBI JI Innovation, LIFESCI 100 Plus Management Partnerships. Orasis pharmaceuticals raised in total approximately $13,000,000 million.

The ERM team was led by Adv. Natalie Noy, partner head of our Hi-Tech practice and Adv. Raz Mechalovich.

For media coverage of the investment, please click here.

Download as PDF
Share:

Deals -

Israir Airlines Completes the Acquisition of 75% of Bird Aviation’s Shares

We congratulate our client, Israir Airlines, on completing the acquisition of 75% of the shares in the Cypriot logistics company Bird Aviation. The deal was overseen by Attorney Nimrod Rosenblum – Managing Partner and Head of the Mergers and Acquisitions Department, and Adv. Michal Gazit and Adv. Noam Zimmerman – Attornies in our Mergers and […]

News -

The IIA Matching Fund

Ron Abelski, Partner in our Corporate, M&A, and High-Tech departments and head of our German desk, in an interview for Relevant podcast regarding the launch of the IIA matching fund to encourage investments by institutional investors in the high-tech industry through Israeli venture capital funds. Watch the full podcast interview here, in Hebrew: Tech Talk with […]

Media